Christopher Pierce Net Worth & Insider Trades

Christopher Pierce - EVP and Chief Business Oper, Prelude Therapeutics Inc

As of September 7, 2021

What is Christopher Pierce's Net Worth?

The current estimated net worth of Prelude Therapeutics Inc's EVP and Chief Business Oper, Christopher Pierce, is estimated to be about $904.98K . Christopher Pierce owns about 3,750 units of Prelude Therapeutics Inc common stock. In the last year at Prelude Therapeutics Inc, Christopher Pierce has sold an estimated value of $882.45K worth.

What is Christopher Pierce's Past Insider Trading?

Christopher Pierce's largest purchase order was 17,000 units , worth over $218.45K on September 7, 2021. Christopher Pierce's largest sale order was 17,000 units , worth over $708.49K on September 7, 2021. In total, Christopher Pierce has made about 6 transactions over a year of their time at Prelude Therapeutics Inc. Christopher Pierce usually trades in April, with the busiest year in 2021.

Christopher Pierce

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is Christopher Pierce's' Mailing Address?

  • Mailing address is C/o Prelude Therapeutics Incorporated 200 Powder Mill Road Wilmington DE 19803 DE

What are Prelude Therapeutics Inc's Past Insider Trades?

Prelude Therapeutics Inc's most recent insider trade came on May 26, 2023 by Krishna Vaddi who bought 1,900 units worth $9.79K . In the last 3 years, insiders at Prelude Therapeutics Inc have sold an estimated value of $10.4M and bought an estimated value of $89.47M worth of shares. Insider trading is most common in April, with the busiest year in 2021. The most active traders at the company are David Mauro, Chief Medical Officer,  Laurent Chardonnet, Chief Financial Officer,  and Peggy Scherle, Chief Scientific Officer .

Prelude Therapeutics Inc Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...